Therapeutic effect of cefdinir for urinary tract infection
Abstract
Objective To evaluate the clinical efficacy and safety of cefdinir in the treatment of urinary tract infection.Methods 126 patients were randomly divided into two groups.Treatment group 63 cases were offered cefdinir capsules 0.1g,orally 3 times a day,control group 63 cases 0.1 g Levofloxacin Lactate Tablets,orally 2 times a day,7 or 14 days was a course of treatment.Results The total effective rate of cefdinir group and levofloxacin group was 96.8% and 82.5% respectively(P 0.05),the bacterial clearance rates were 95.7% and 84.7%(P 0.01),and the incidence of adverse reactions was 6.3% and 7.9%,respectively.Conclusions Cefdinir is safe and effective drug for treating urinary tract infection.
Read the paper
Related studies
- Association of lower urinary tract symptoms and OAB severity with quality of life and mental health in China, Taiwan and South Korea: results from a cross-sectional, population-based study
- Ten-Day Quadruple Therapy Comprising Low-Dose Rabeprazole, Bismuth, Amoxicillin, and Tetracycline Is an Effective and Safe First-Line Treatment for Helicobacter pylori Infection in a Population with High Antibiotic Resistance: a Prospective, Multicenter, Randomized, Parallel-Controlled Clinical Trial in China
- The Role of the NLR and PLR in Urinary Tract Infection
- Threat of Antimicrobial Resistance among Pilgrims with Infectious Diseases during Hajj: Lessons Learnt from COVID-19 Pandemic
- Leclercia adecarboxylata urinary tract infection in a patient with bladder cancer and recurrent hematuria
- A Case Series of Staphylococcus lugdunensis Infection in Cancer Patients at an Academic Cancer Institute in the United States
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.